Most Recent
Mastercard has lost a bid to patent a data processing system used to prevent fraud on payment card networks, with an IP delegate Australia ruling the invention “does not rise above an idea.”
The High Court has unanimously dismissed Western Power’s challenge to a judgment which found the state-owned electricity supplier breached its duty of care to inspect power poles on private land and was partly liable for property damage from the 2014 Perth Hills bushfire.
A judge has imposed a $21 million penalty on Uber for misleading customers through platform-wide cancellation messages and estimated fares on its Uber Taxi option, $5 million short of the “very substantial” sum jointly agreed by the parties.
Carnival unit P&O Cruises has been hit with a class action by passengers who say their holidays were ruined by norovirus outbreaks on its Sun Princess cruise ship.
ASIC has taken American Express Australia to court over two credit cards co-branded with department store David Jones which the regulator alleges customers mistakenly believed were loyalty cards.
A judge has rejected barrister Gina Edwards’ “somewhat speculative” bid to issue interrogatories to Nine, weeks out from trial in a defamation case brought over the media company’s coverage of her custody battle for famed social media pooch Oscar the cavoodle.
Aluminium giant Alcoa has sued AusNet and Powercor over a 2016 power outage that left the future of its Victorian smelter site in doubt.
Former defence minister Linda Reynolds is facing a civil suit by former staffer Brittany Higgins in relation to her alleged rape inside Reynold’s Parliament House office in 2019.
Westpac has lost a bid to keep group members in the dark about the premiums paid for allegedly worthless consumer credit insurance, information the bank said could inflate expectations about settlements worth $126 million reached in three class actions.
Israeli drug company Neurim Pharmaceuticals has lost a bid to patent a mini version of its melatonin tablet Circadin for children, after a successful challenge by Australian drug maker Generic Partners.